Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists

Lip, Gregory Y.H. ; Rasmussen, Lars H. ; Olsson, S. Bertil ; Jensen, Eva C. ; Persson, Anders L. ; Eriksson, Ulf ; Wåhlander, Karin F.C.

European heart journal, 2009-12, Vol.30 (23), p.2897-2907 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível